Ingestible Smart Pills Market
Global Ingestible Smart Pills Market Size, Share, and Trends Analysis Report, by Component (Smart Pills (Patient Monitoring and Capsule Endoscopy (Small Bowel Endoscopy, Esophagus Endoscopy, and Colon Endoscopy)) and Workstation), Application (Imaging and Monitoring), and By End-User (Hospital, Clinics, Research Institutes, and Homecare), Forecast Period (2022-2028) Update Available - Forecast 2024-2030
The global ingestible smart pills market is anticipated to grow at a CAGR of 6.2% during the forecast period. The increasing cases of gastroparesis in the developed nations, including the US and UK are giving strength to the market growth. However, the high requirement of R&D investment for the designing of miniaturized microelectronics is restraining the growth of the market. Additionally, stringent government regulations are another hurdle in the development of the market.
Ingestible smart pills are used for capsule endoscopy, patient monitoring, and controlled drug delivery application in the medical sector. Ingestible smart pills can help in tracking the pH and temperature of a patient's gastrointestinal tract and also provide images of the targeted organs. These are also known as intelligent pills. The rising cases of chronic diseases and medical adherence are driving the growth of the global ingestible smart pills market. For instance, according to the Royal Melbourne Institute of Technology, one out of every five people suffers from a gastrointestinal disorder globally in their lifetime and 30% of them remain undiagnosed. The accuracy requirement in invasive diagnosis tests is creating huge opportunities for innovation in ingestible smart pills. This report will further analyze all the primary as well as secondary factors that are directly or indirectly impacting the growth of the market.
The outbreak of COVID-19 had greatly impacted the global ingestible smart pills market. According to the research of the Swedish Medical Center, COVID-19 had reduced around 83% of the total endoscopy volumes globally. Out of this 82% reduction was recorded in upper endoscopy and 85% was recorded in lower endoscopy. As endoscopy is the major end-use of ingestible smart pills, thus it experienced a major downfall during the pandemic. However, the Oceania region had recorded normal endoscopy procedures during the COVID-19 pandemic.
Segmental Outlook
The global ingestible smart pills market is segmented based on the component, application, and end-user. Based on the component, the market is segmented into smart pills and workstations. The smart pills segment is further segmented as patient monitoring and capsule endoscopy. The capsule endoscopy includes small bowel endoscopy, esophagus endoscopy, and colon endoscopy. Based on the application, the market is sub-segmented into imaging and monitoring.
Based on the end-user, the market is sub-segmented as hospitals, clinics, research institutes, and homecare. Among these end-users, the research institutes segment is anticipated to hold a significant share in the market owing to the rising R&D activities related to life science. The homecare segment is expected to grow considerably during the forecast period for the continuous monitoring of the health of the patient pursuing health treatment from home. The above-mentioned segments can also be customized as per the requirements.
Regional Outlooks
The global ingestible smart pills market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). The market can also be analyzed for a particular region or country level as per the requirement.
Global Ingestible Smart Pills Market Growth by Region, 2022-2028
The North American Region Holds a Significant Share in the Global Ingestible Smart Pills Market
North America held the largest market share in the global market owing to the growing need for smart pills and monitoring devices. The high prevalence of lifestyle-related diseases in the US has further boosted the growth of the ingestible smart pills market in North America. The Centers for Disease Control and Prevention estimated that 37.3 million people were living with diabetes in the US in 2020.
The rapidly developing economies of Asia-Pacific are projected to witness the highest growth rate during the forecast period. The growth in the Asia-Pacific region is backed by the rising awareness about the diagnosis and treatment options for chronic diseases coupled with the rising prevalence of lifestyle-related diseases such as diabetes. Along with it, efforts by government agencies on research and funding programs are also helping in the growth of the Asia-Pacific ingestible smart pills market.
Market Players Outlook
The major companies serving the global ingestible smart pills market include GE Healthcare, Siemens AG, Novartis International AG, Boston Scientific Corp., Medimetrics, IntroMedic Co., Ltd., Philips Healthcare, and Medtronic plc, among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, Olympus Corp. had launched PowerSpiral in March 2019 in Europe and the Asia-Pacific region. PowerSpiral have motorized rotating attachments through which the small intestine can also be endoscope.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global ingestible smart pills market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. GE Healthcare
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Siemens AG
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Novartis International AG
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.2. Key Strategy Analysis
4. Market Segmentation
4.1. Global Ingestible Smart Pills Market by Component
4.1.1. Smart Pills
4.1.1.1. Patient Monitoring
4.1.1.2. Capsule Endoscopy
4.1.1.2.1. Small Bowel Endoscopy
4.1.1.2.2. Esophagus Endoscopy
4.1.1.2.3. Colon Endoscopy
4.1.2. Workstation
4.2. Global Ingestible Smart Pills Market by Application
4.2.1. Imaging
4.2.2. Monitoring
4.3. Global Ingestible Smart Pills Market by End-User
4.3.1. Hospitals
4.3.2. Clinics
4.3.3. Research Institutes
4.3.4. Homecare
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. BodyCap Medical
6.2. Boston Scientific Corp.
6.3. CapsoVision, Inc.
6.4. Check-Cap Ltd.
6.5. Chongqing Jinshan Science and Component (Group) Co., Ltd.
6.6. etectRx, Inc.
6.7. Given Imaging Ltd.
6.8. HQ Inc.
6.9. Medimetrics, IntroMedic Co., Ltd.
6.10. Medtronic plc
6.11. Olympus Corp.
6.12. Pentax Medical Co. (HOYA Corp.)
6.13. Philips Healthcare
6.14. Proteus Digital Health, Inc.
6.15. Smart Pill Inc.
6.16. Stryker Corp?
1. GLOBAL INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2021-2028 ($ MILLION)
2. GLOBAL SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL SMART PILLS FOR PATIENTS MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL SMART PILLS FOR CAPSULE ENDOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5. GLOBAL SMALL BOWEL ENDOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL ESOPHAGUS ENDOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL COLON ENDOSCOPY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8. GLOBAL WORKSTATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
9. GLOBAL INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
10. GLOBAL IMAGING INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11. GLOBAL MONITORING INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12. GLOBAL INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
13. GLOBAL HOSPITAL INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14. GLOBAL CLINICS INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15. GLOBAL RESEARCH INSTITUTES INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
16. GLOBAL HOMECARE INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17. GLOBAL INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18. NORTH AMERICAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
19. NORTH AMERICAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2021-2028 ($ MILLION)
20. NORTH AMERICAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
21. NORTH AMERICAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
22. EUROPEAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
23. EUROPEAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2021-2028 ($ MILLION)
24. EUROPEAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
25. EUROPEAN INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
26. ASIA-PACIFIC INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
27. ASIA-PACIFIC INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2021-2028 ($ MILLION)
28. ASIA-PACIFIC INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
29. ASIA-PACIFIC INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
30. REST OF THE WORLD INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
31. REST OF THE WORLD INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY COMPONENT, 2021-2028 ($ MILLION)
32. REST OF THE WORLD INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
33. REST OF THE WORLD INGESTIBLE SMART PILLS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1. GLOBAL INGESTIBLE SMART PILLS MARKET SHARE BY COMPONENT, 2021 VS 2028 (%)
2. GLOBAL SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
3. GLOBAL SMART PILLS FOR PATIENTS MONITORING MARKET SHARE BY REGION, 2021 VS 2028 (%)
4. GLOBAL SMART PILLS FOR CAPSULE ENDOSCOPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
5. GLOBAL SMALL BOWEL ENDOSCOPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
6. GLOBAL ESOPHAGUS ENDOSCOPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
7. GLOBAL COLON ENDOSCOPY MARKET SHARE BY REGION, 2021 VS 2028 (%)
8. GLOBAL WORKSTATION MARKET SHARE BY REGION, 2021 VS 2028 (%)
9. GLOBAL INGESTIBLE SMART PILLS MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
10. GLOBAL IMAGING INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
11. GLOBAL MONITORING INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
12. GLOBAL INGESTIBLE SMART PILLS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
13. GLOBAL HOSPITAL INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
14. GLOBAL CLINICS INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
15. GLOBAL RESEARCH INSTITUTES INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
16. GLOBAL HOMECARE INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
17. GLOBAL INGESTIBLE SMART PILLS MARKET SHARE BY REGION, 2021 VS 2028 (%)
18. US INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
19. CANADA INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
20. UK INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
21. FRANCE INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
22. GERMANY INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
23. ITALY INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
24. SPAIN INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
25. REST OF EUROPE INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
26. INDIA INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
27. CHINA INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
28. JAPAN INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
29. REST OF ASIA-PACIFIC INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
30. REST OF THE WORLD INGESTIBLE SMART PILLS MARKET SIZE, 2021-2028 ($ MILLION)
